CWM, LLC
- SEC CIK
- 0001535847
- Latest filing
- May 14, 2026
EGRX holding history
Eagle Pharmaceuticals, Inc. in every 13F filed by CWM, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EGRX overviewAll 13F holders of EGRXFull Q1 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −1,672−100.0% | Sold out | Holders |
| Q2 2024 | 1,672 | $9.00K | <0.1% | −565−25.3% | Reduced | Holders |
| Q1 2024 | 2,237 | $12.0K | <0.1% | −2,085−48.2% | Reduced | Holders |
| Q4 2023 | 4,322 | $23.0K | <0.1% | +3,258+306.2% | Added | Holders |
| Q3 2023 | 1,064 | $17.0K | <0.1% | +484+83.4% | Added | Holders |
| Q2 2023 | 580 | $11.0K | <0.1% | +454+360.3% | Added | Holders |
| Q1 2023 | 126 | $4.00K | <0.1% | −110−46.6% | Reduced | Holders |
| Q4 2022 | 236 | $7.00K | <0.1% | +68+40.5% | Added | Holders |
| Q3 2022 | 168 | $4.00K | <0.1% | +168 | New | Holders |